This is an excellent PhD opportunity for anyone interested in developing advanced brain cellular models and engaging in interdisciplinary research. If this aligns with your interests or career trajectory, consider applying.
Questions? Follow the link below or reach out to the PI: Mattéa Finelli.
09.12.2025 19:09 — 👍 1 🔁 0 💬 0 📌 0
PhD Opportunities – MRC AIM
Exciting MRC funded PhD opportunity to develop an animal free 3D brain model with UoN, UoB and PeptiMatrix. Great project for anyone interested in stem cells and drug discovery.
Apply by 9 Jan 2026: more.bham.ac.uk/mrc-aim/phd-...
09.12.2025 13:56 — 👍 0 🔁 1 💬 0 📌 1
Congratulations 🎉
05.06.2025 06:15 — 👍 2 🔁 0 💬 0 📌 0
🧠Sharing this Starter Pack again as the list has now reached 80 people! A great mix of Profs/PIs/Post-docs/PhDs/Technicians.
Please re-post so it can reach a wider audience as I'm sure there are more of us out there ☺️🦋
go.bsky.app/S6FfsTp
19.11.2024 14:15 — 👍 20 🔁 19 💬 0 📌 0
OpenBind is building the world’s largest open-access dataset of drug–protein interactions to speed up new treatments. Through cutting-edge science and open collaboration, we power AI tools for structure-based drug design – free for all.
Assistant Prof of Biochemistry & Chemistry @ LMU | Metabolic enzymes of bioremediating bacteria. Making biochemistry fun & accessible #biochemsky #chemsky
http://thebumblingbiochemist.com/ & https://www.youtube.com/@thebumblingbiochemist
Advancing understanding of the gut-immune-brain axis (GIBA).
Researcher @ UC Berkeley Advanced BioImaging Center, MCB Department, Evo-devo-cell biologist, 🎷👨🍳🐕🐈⬛
Research and development company leveraging the biology of diverse organisms. Read about our science: http://research.arcadiascience.com
DVM; PhD-ing Neuroscience🧠 @uOttawaMed @OHRI 🇨🇦
Molecular, Cell & Developmental Biologist using #AI4Microscopy to study Neurodevelopmental disorders.
Views are my own.
Pastel BioScience | t.ly/y4tAy
Proteomics conferences here >>> t.ly/GSBz-
Proteomics databases and scripts here >>> t.ly/iNYXg
International Open Access journal publishing on molecular and translational medicine. IF 2024,9.4; Scopus Citescore 2024, 8.4.
Post doc in the Patani Lab at the National University of Singapore, interested in the role of glia in motor neuron disease using iPSC models
We use human stem cell models to understand a range of neurodegenerative disorders, with particular focus on RNA metabolism and cellular autonomy. We are based at the National University of Singapore in the LSI: https://www.nus.edu.sg/lsi/
Associate Professor at Columbia Chemistry. PI of a chemical biology lab full of awesome people. Internal conflicts: Chemist or biologist? Kinase or phosphatase?
Lab website: https://shahlab.wixsite.com/home
ORCiD: 0000-0002-1186-0626
💻 👾 Decoding protein structure and biological networks to drive drug discovery and precision medicine. 🧪 🔬 🧬
Led by @ptck72.bsky.social at @irbbarcelona.org
#sbnblab #generativeAI #computationalbiology
Signal Transduction and Targeted Therapy (STTT) | A Nature Portfolio journal | Impact Factor 52.7 | Q1 in Biochemistry, Cell Biology & Molecular Medicine | Open Access
Visit: https://www.nature.com/sigtrans/
A fully open access, peer-reviewed journal published jointly by Oxford University Press and the International Society for Computational Biology.
Next generation peptide hydrogels for 3D cell culture | Nottingham | UK
I'm a scientist studying resilience w/ children & families who experience adversity, like homelessness & loss.
RG: www.researchgate.net/profile/J-J-Cutuli/publications
Substack: https://joewillard.substack.com/
Fighting mito, finding hope
Our vision is for a world in which every mitochondrial disease patient has a voice and access to treatment, support to improve their life and, ultimately, a cure.
https://www.thelilyfoundation.org.uk/
#mitochondrialdisease
www.MitoWorld.org is a global mitochondria research, information and media hub which intends to be inclusive across the many mitochondria communities to promote mitochondria broadly to the public, to medicine, health advocates and education.
